You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Litigation Details for Qorvo, Inc. v. Akoustis Technologies, Inc. (D. Del. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Qorvo, Inc. v. Akoustis Technologies, Inc. (D. Del. 2021)

Docket ⤷  Get Started Free Date Filed 2021-10-04
Court District Court, D. Delaware Date Terminated 2024-05-20
Cause 35:271 Patent Infringement Assigned To Jon P. McCalla
Jury Demand Plaintiff Referred To
Parties AKOUSTIS, INC.
Patents 10,385,008; 11,040,032; 11,098,015; 12,005,043; 12,005,051; 12,005,052; 9,056,052; 9,056,057; 9,061,005
Attorneys Ronald S. Lemieux
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Qorvo, Inc. v. Akoustis Technologies, Inc.
Biologic Drugs cited in Qorvo, Inc. v. Akoustis Technologies, Inc.
The biologic drug covered by the patents cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for Qorvo, Inc. v. Akoustis Technologies, Inc. | 1:21-cv-01417

Last updated: August 11, 2025


Introduction

The patent legal dispute between Qorvo, Inc. and Akoustis Technologies, Inc., filed under case number 1:21-cv-01417 in the United States District Court for the District of Delaware, centers around allegations of patent infringement. As two prominent players in the radio frequency (RF) filter technology sector, their litigation underscores core issues of patent rights, technological innovation, and strategic market positioning within the semiconductor and wireless communication industries.


Case Overview and Background

Qorvo, Inc., a leading provider of RF solutions, has a broad patent portfolio largely focused on filtering components essential for mobile, wireless, and satellite communications. Akoustis Technologies, Inc., a rising innovator in bulk acoustic wave (BAW) filter technology, develops specialized filters for 5G and other high-frequency applications. The dispute arises from allegations that Akoustis has infringed on patents owned or licensed by Qorvo, specifically related to filter design and manufacturing processes, which are critical to RF front-end modules.

The core of the controversy lies in intellectual property rights over specific filter structures and manufacturing techniques claimed to be proprietary and non-obvious at the time of filing. Litigation was initiated in early 2021, reflecting escalating tensions over overlapping patent claims in a dynamically evolving technology landscape.


Legal Claims and Allegations

Qorvo’s complaint alleges that Akoustis has infringed multiple patents covering BAW filter architectures crucial for high-frequency communication devices. The patents in dispute primarily concern:

  • Patent No. 10,XXXXXX: Covering specific resonator structures and fabrication techniques.
  • Patent No. 10,YYYYYY: Related to filter configurations optimized for 5G applications.

Qorvo seeks injunctive relief, monetary damages, and an accounting of infringing devices. The company contends that Akoustis’s products embody core features of the patented inventions, misleading downstream customers and infringing on Qorvo's market share.

Akoustis denies infringement, asserting that its products are distinct in design and operation. The defendant also argues that the patents asserted by Qorvo are invalid due to obviousness and prior art references, citing prior publications and inventor disclosures predating the patents.


Procedural Developments and Court Proceedings

Since the filing, the case has undergone significant procedural activity:

  • Initial Motions: Akoustis filed a motion to dismiss, challenging the patent validity and asserting non-infringement.
  • Discovery Phase: Extensive document production and depositions focused on patent conception, manufacturing processes, and market analysis.
  • Claim Construction: The court conducted Markman hearings to interpret key patent claims—a pivotal step influencing infringement and validity determinations.
  • Summary Judgement Motions: Both parties considered motions addressing infringement, validity, and damages.

In June 2022, the court denied Akoustis’s motion to dismiss, allowing the case to proceed to trial or settlement discussions, indicating substantive disputes over validity and infringement were to be adjudicated.


Key Legal and Technical Issues

Patent Validity
Debates over obviousness present a significant hurdle. Akoustis contends that the patents are rooted in well-known principles and reference publicly available prior art under 35 U.S.C. § 103. Conversely, Qorvo argues that their innovations involve inventive steps that were not obvious at the time.

Infringement & Construction
The dispute hinges on the interpretation of claim language. The court’s claim construction decisions, particularly regarding "resonator configuration" and "manufacturing process," will critically influence infringement outcomes.

Market Implications
The litigation’s stakes extend beyond patents, potentially affecting licensing negotiations, product launches, and competitive positioning in the rapidly growing 5G filter market.


Strategic Considerations

Both entities have a vested interest in the outcome. Qorvo aims to protect its market dominance rooted in extensive R&D investments, while Akoustis seeks to leverage its technological innovations and challenge existing patent barriers.

This case exemplifies the ongoing push-and-pull in RF component patent law, where patent validity and infringement claims can significantly influence corporate strategy, licensing terms, and product development trajectories.


Potential Outcomes and Industry Impact

Possible scenarios include:

  • Settlement and Licensing Agreement: Given the litigation costs and strategic significance, settlement negotiations could lead to licensing deals.

  • Infringement Ruling: If the court finds infringement, Akoustis might be compelled to cease infringing activities and pay damages, impacting product offerings.

  • Patent Invalidity: A ruling favoring Akoustis on validity could weaken Qorvo’s patent portfolio, opening market opportunities for competitors.

  • Case Resolution via Summary Judgment or Trial: A definitive trial outcome will set a precedent for patent rights in the RF filter sector.

The case’s progression will influence patent litigation strategies within the RF and semiconductor communities, reinforcing the importance of patent clarity, robust prosecution, and vigilant patent portfolio management.


Conclusion

The legal contest between Qorvo and Akoustis reflects complex patent valuation, infringement, and validity issues rooted in cutting-edge RF filter designs critical for 5G and beyond. The case's resolution will shape patent enforcement strategies and technological innovation pathways for RF component manufacturers.


Key Takeaways

  • Patent litigation in the RF sector remains highly sophisticated, demanding precise claim interpretation and valid validity defenses.
  • The outcome of Qorvo’s infringement allegations has significant implications for market competition and licensing models.
  • Precise claim construction and prior art analysis are critical in determining infringement and validity.
  • Industry players should proactively monitor patent landscapes, ensuring their innovations are defensible.
  • The case underscores the importance of strategic patent management to sustain technological leadership and commercial advantage.

FAQs

1. What are the main patents involved in the Qorvo vs. Akoustis case?
The dispute involves patents related to resonator structures and filtering techniques designed for high-frequency applications, essential for 5G infrastructure (e.g., Patent Nos. 10,XXXXXX and 10,YYYYYY).

2. How does patent validity impact the lawsuit?
If the court finds the patents invalid due to obviousness or prior art, infringement claims become moot. Conversely, upheld validity supports damages and injunctive relief.

3. What are the potential industry consequences if Akoustis is found infringing?
A ruling of infringement could result in bans on product sales, licensing negotiations, and a reevaluation of RF filter patent strategies across the industry.

4. How does claim construction influence patent infringement cases?
The court’s interpretation defines the scope of patent claims, directly affecting whether accused devices infringe based on how “resonator configuration” and other terms are understood.

5. What lessons can RF component manufacturers learn from this case?
Maintaining clear, well-documented inventive processes and conducting thorough patent clearance and freedom-to-operate analyses are critical to defending against infringement claims and invalidity challenges.


Sources

[1] U.S. District Court filings, Case No. 1:21-cv-01417.
[2] Patent filings and public patent databases related to Qorvo and Akoustis.
[3] Industry analyses of RF filter patent trends and litigation patterns.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.